Valiant Navion™ VNMC3434C223TU (UDI 00763000260828)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC3434C223TU VAL NAV CS · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00763000260828), received between Jul 15, 2020 and Jan 23, 2023 — classified as 4 injuries.
The most frequently reported specific device problem is “Leak/Splash” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Leak/Splash4
- Adverse Event Without Identified Device or Use Problem1
- Migration or Expulsion of Device1
Patient problems
- Insufficient Information2
- Injury1
- No Clinical Signs, Symptoms or Conditions1
- Pain1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJan 23, 2023Leak/Splash; Adverse Event Without Identified Device or Use Problem; Leak/Splash; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC DISSECTION. IT IS NOTED THIS PATIENT HAS ADDITIONAL DEVICES - (LEFT CAROTID SUBCLAVIAN BYPASS 8MM NON MDT GRAFT AND LSCA EMBOLIZATION COILS. IT WAS REPORTED POST THE INDEX PROCEDURE A TYPE IB ENDOELAK WAS OBSERVED. FOLLOW UP ONE MONTH POST THE INDEX PROCEDURE DEMONSTRATED AORTIC ENLARGEMENT. REINTERVENTION WAS COMPLETED WHERE AN ADDITIONAL VALIANT NAVION GRAFT WAS IMPLANTED. PER THE PHYSICIAN THE CAUSE OF THE TYPE IB ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Insufficient Information
MAUDE report 16223076 ↗InjuryFeb 24, 2022Leak/Splash; Migration or Expulsion of Device; Leak/Splash; Migration or Expulsion of Device
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING AN ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION. IT WAS REPORTED FROM A CT TAKEN UNDER A MONTH LATER THAT THE THERE WAS EVIDENCE OF PERFUSION FROM PROXIMAL ENTRY TEAR, A TYPE IA ENDOLEAK. THE MAXIMUM AORTIC DIAMETER MEASURED 60MM. NO RELATED ASSESSMENT HAS BEEN PROVIDED. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions; Vascular Dissection
MAUDE report 13590534 ↗InjuryJan 21, 2021Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A UNKNOWN SIZE RUPTURED THORACIC AORTIC ANEURYSM. IT WAS REPORTED 5 DAYS LATER, THE PATIENT WAS EXPERIENCING RECURRENT BACK PAIN. A CT SCAN WAS PERFORMED WHICH SHOWED A POSSIBLE IA ENDOLEAK OR IIIB ENDOLEAK. THE PATIENT WAS BROUGHT TO OR AND ALTHOUGH AN ENDOLEAK COULD NOT BE ANGIOGRAPHICALLY RECONFIRMED, THE STENT GRAFT WAS RELINED WITH ANOTHER VALIANT NAVION DEVICE. NO CAUSE OF THE EVENT WAS REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.
Patient problems: Pain
MAUDE report 11207216 ↗InjuryJul 15, 2020Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED FOR A 30-40 MM THORACIC AORTIC DISSECTION. IT WAS REPORTED THAT APPROXIMATELY 3 DAYS LATER, A CT WAS PERFORMED AND A TYPE IA ENDOLEAK WAS OBSERVED. BALLOONING WAS THEN PERFORMED PROXIMALLY WHICH RESOLVED THE ENDOLEAK. AS PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS THAT THE PIGTAIL CATHETER DURING THE INDEX PROCEDURE WAS NOT PLACED IN THE PROXIMAL ASPECT OF THE GRAFT AND AS A RESULT THE LEAK WAS NOT SEEN THEN. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.
Patient problems: Injury
MAUDE report 10275354 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page